Published online before print November 21, 2007, doi: 10.1161/STROKEAHA.107.486134
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:191.)
© 2008 American Heart Association, Inc.
Original Contributions |
Responses of Endothelial Cell and Astrocyte Matrix-Integrin Receptors to Ischemia Mimic Those Observed in the Neurovascular Unit
From the Department of Molecular and Experimental Medicine (R.M., S.H., X.W., G.I.B., G.J.d.Z.), The Scripps Research Institute, La Jolla, Ca; Departments of Medicine and Neurology (G.J.d.Z.), University of Washington, Seattle, Wash; and the Stroke Branch (M.S.), National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Md, USA.
Correspondence to Gregory J. del Zoppo, MD, Departments of Medicine and Neurology, University of Washington, at Harborview Medical Center, 325 Ninth Ave, Box 359756, Seattle, WA 98104. E-mail grgdlzop{at}u.washington.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Background and Purpose— Apposition of endothelial cells and astrocyte foot processes to the basal lamina matrix is postulated to underlie the cerebral microvessel permeability barrier. Focal cerebral ischemia induces rapid loss of select matrix-binding integrins from both cell compartments in the nonhuman primate. This study is the first to examine the conditions underlying integrin loss from these cell-types during ischemia in vitro and their relation to the changes in vivo.
Methods— The impact of normoxia or standardized oxygen-glucose deprivation on integrin expression by murine primary cerebral endothelial cells and astrocytes grown on matrix substrates (collagen IV, laminin, and perlecan) of the basal lamina were quantitatively assessed by flow cytometry.
Results— Endothelial cell expression of the β1 and 
5 subunits significantly increased on all matrix ligands, whereas astrocytes displayed modest significant decreases in 5 and 6 subunits. Oxygen-glucose deprivation produced a further significant increase in subunit β1 expression by both cell types, but a clear decrease in both 1 and 6 subunits by murine astrocytes.
Conclusions— Ischemia in vitro significantly increased endothelial cell β1 expression, which is consistent with the increase in β1 transcription by microvessels peripheral to the ischemic core. The loss of 1 and 6 integrins from murine astrocytes is identical to that seen in the nonhuman primate in vivo. These findings establish both isolated murine cerebral endothelial cells and astrocytes as potential integrin response cognates of microvascular cells of the neurovascular unit in primates, and allow determination of the mechanisms of their changes to ischemia.
Key Words: astrocytes • endothelial cells • integrins • ischemic stroke • matrix
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The cerebral microvasculature is highly specialized. Cerebral microvessels are relatively impermeable, displaying elevated electrical resistance compared with microvessels within other organs,1–4 one of the properties often referred to as the microvascular blood-brain barrier. The cellular portion of the barrier protects sensitive neurons from contact with potentially toxic activated plasma proteases (eg, thrombin).1,3,5 The molecular basis of the cellular portion of this barrier has been attributed to interendothelial cell tight junctions.1,6,7 Endothelial cells are also attached to the vascular basal lamina, where their functional properties are strongly influenced by astrocytes that abut the abluminal face of the basal lamina.8–12 The basal lamina matrix constitutes the second functional barrier that limits movement between blood and the brain parenchyma.13
Several lines of evidence suggest that select integrin matrix adhesion receptors expressed by endothelial cells and astrocytes play an important role in maintaining the permeability barrier.14–17 Expression of these extracellular matrix (ECM) receptors is perturbed during pathological states of the central nervous system, including focal cerebral ischemia, multiple sclerosis, and nerve degeneration.18–20 Transgenic mice deficient in integrins v and β8 subunits show breakdown and leakage of cerebral blood vessels during development.21,22
Focal cerebral ischemia induces a rapid loss of β1 integrin expression by endothelial cells and astrocytes.23–25 Within 2 hours after middle cerebral artery occlusion in the nonhuman primate, the basal lamina matrix component perlecan (HSPG) decreases by 43% to 63%.26 These changes coincide with an increase in vascular permeability.27 A more gradual loss in microvessel-associated laminins-1 and -5, cellular fibronectin, and type IV collagen within the ischemic territory also occurs.13 The rapidity of the loss in select integrin expression together with specific matrix alterations in cerebral microvessels plus their known roles in cell viability suggest that these postischemic alterations may be relevant to edema formation, detachment of astrocyte end-feet during focal ischemia, and hemorrhagic transformation. But, identifying the mechanisms underlying the ischemia-induced integrin-matrix responses requires isolation of the cell components.
To establish identity between in vitro cell culture responses and brain tissue responses, and to elucidate the mechanisms regulating integrin expression, we examined how integrin expression by endothelial cells and astrocytes is managed, first by ECM proteins present in the basal lamina of cerebral vessels, then by standardized ischemia in vitro (oxygen glucose deprivation [OGD]). The tested hypothesis states that: (1) expression of select integrins by endothelial cells and astrocyte end-feet within cerebral microvessels of the (primate) neurovascular unit can be recapitulated in vitro, (2) the response to OGD coincides with the impact of focal ischemia on the cells in vivo, and (3) these responses are conserved between the 2 species. These experiments are intended as the basis for investigating the mechanisms of interactions between endothelial cells and astrocytes within the neurovascular unit of the primate cerebrum.25
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Animals
The studies described here have been reviewed and approved by The Scripps Research Institute Institutional Animal Care and Use Committee. All animals were maintained under pathogen-free conditions in the closed breeding colony of The Scripps Research Institute (TSRI).
Cell Culture
Mouse primary brain endothelial cells were prepared as previously described,28 according to the method of Sapatino,29 with some modifications. Brains of adult C57BL6 mice (2 to 3 months old; The Scripps Research Institute, and Jackson Laboratories) were removed, cleaned of meninges and external blood vessels, then finely chopped, and dissociated for 1 hour in an enzymatic solution containing 30 U/mL papain (Worthington Biochemicals, Lorne Laboratories), 0.24 mg/mL L-cysteine (Sigma), and 40 µg/mL DNAse I type IV (Sigma) in 1 mL MEM-HEPES, as previously described for mixed glial cultures.30 After incubation, the disrupted brain tissue was triturated, added to a 15-mL tube containing 22% bovine serum albumin (BSA), and centrifuged at 1000g for 10 minutes (in order to separate out the myelin, retarded at the top of the tube, from the vascular tubes and other cells at the bottom of the tube). The collected vascular tubes and cells were resuspended and filtered through a 40-µm cell strainer (Falcon) to separate the vascular tubes from single cells. The tubes were then washed and centrifuged in MEM-HEPES before being resuspended in endothelial cell growth media consisting of Hams F12, supplemented with 10% FCS, heparin, ascorbic acid, L-glutamine (all from Sigma) and endothelial cell growth supplement (Upstate Cell Signaling Solutions, Lake Placid, NY). The endothelial cells were then added to 6-well plates, previously coated for 2 hours with type I collagen (Sigma), and grown in a humidified incubator at 37°C and 5% CO2. Assessed by live immunostaining for the endothelial cell surface markers CD31 (PECAM-1) and CD105 (endoglin), endothelial cell cultures were determined as >95% pure. In these experiments endothelial cells were used only for the first 2 passages.
Astrocytes were obtained as previously described using a technique modified from McCarthy and De Villis.30–32 Briefly, primary mixed glial cultures were established from the forebrains of postnatal C57Bl6 mice by dissociating cortices in papain and then growing the resulting cell suspension for 
10 days in DMEM supplemented with 10% fetal bovine serum. After 10 days, the flasks were shaken overnight to remove the loosely attached microglia and oligodendrocyte precursors. The remaining monolayer was determined as >95% astrocytes by immunoreactivity to antibodies against glial fibrillary acidic protein.
Preparation of ECM Protein Substrates
Individual wells within 6-well plates even coated with solutions containing collagen I, collagen IV, fibronectin, laminin (all prepared at 10 µg/mL in PBS) or perlecan (1 µg/mL; Sigma) for 2 hours at 37°C, before use. These substrates were then washed with 2 mL PBS. Brain endothelial cells or astrocytes that had been removed from primary cultures by trypsinization were then plated onto the ECM substrates and cultured in endothelial cell growth media– or DMEM-containing 10% FBS respectively.
Oxygen-Glucose Deprivation
To investigate the influence of OGD on integrin expression, endothelial cells and astrocytes were cultured on 3 ECM substrates: collagen IV, laminin, or HSPG. On reaching confluence, the cell media was changed, with half the cultures receiving normal media (high glucose, 4.5 g/L), and the other half receiving low-glucose media (1 g/L). High-glucose cultures were exposed to normoxia for 18 hours. The low-glucose cultures were exposed to OGD for 18 hours, achieved by placing the cultures into a hypoxia chamber (Billups-Rothenburg), and flushing through the chamber with 95%N2/5%CO2 for 1 hour, then sealing the chamber for the duration of the experiment. In each experiment, within the culture media, measured O2 levels (Microelectrodes Inc) dropped to <3% after 2 hours to <1% after 4 hours, and were maintained at this level for the duration of ischemia in vitro.
Cell Viability Assay
Endothelial cells and astrocytes were cultured on laminin-coated glass coverslips within 24-well plates (Nunc) for 3 days. Cells were then either maintained in normal glucose and ambient O2 levels for 18 hours, or exposed to OGD for 18 hours. Afterward the cells were incubated with 1 µg/mL propidium iodide (PI, Sigma) for 15 minutes at 37°C. The cells were then washed in PBS and fixed at –20°C for 20 minutes before labeling with Hoechst stain (Sigma) for 5 minutes, washed and mounted. The percentage of damaged cells was evaluated by calculating the number of those dead or dying (PI positive) as a proportion of the total (Hoechst positive).
Antibodies
Monoclonal antibodies reactive for the integrin subunits 1 (Ha1/29), 3 (clone 42), 5 (5H10-27 [MFR5]), or 6 (clone GoH3), and the isotype control antibodies, rat anti-KLH (A110-2), mouse anti-TNP (clone 49.2), and hamster anti-TNP (clone A19-3), were obtained from BD Pharmingen (La Jolla, Calif). A monoclonal antibody reactive for the β1 integrin subunit (clone MB1.2) was obtained from Chemicon (Temecula, Calif). The phycoerythrin (PE)-conjugated secondary antibodies were also obtained from BD Pharmingen.
Flow Cytometry
Cell-associated integrin expression was determined as previously described.33 Briefly, endothelial cells and astrocytes were removed from their culture plates using a cell lifter (thereby avoiding the use of enzymes such as trypsin, which cleave cell surface proteins). Cells were blocked in suspension in 5% normal goat serum in PBS for 30 minutes on ice, transferred to wells within a round-bottom 96-well plate (Nunc), and then incubated for 1 hour on ice with primary antibodies specific for individual integrin subunits (antibody concentration 5 µg/mL). Cells were then washed twice in the blocking buffer before being labeled with anti-rat–PE, anti-mouse-PE, or anti-hamster-PE (all at 1 µg/mL) for 1 hour on ice and then washed twice with blocking buffer before being resuspended in 2% formaldehyde in PBS. The fluorescent intensity of labeled cells was then analyzed on a Becton Dickinson FACScan machine, with 10 000 events recorded for each condition. For each experimental condition, the mean fluorescence intensity was compared with the control state and expressed as the percentage change relative to the control condition.
RNA Extraction and Quantitative Real-Time RT-PCR
Total RNA was extracted from astrocytes subjected to normoxia or OGD using the RNeasy Plus Mini kit (QIAGEN). Eluted RNA was treated with DNA-free DNase (Ambion). The RT-PCR reaction was set up according to the recommendation of the SuperScript III Platinum One-Step Quantitative RT-PCR System protocol (Invitrogen). The final reaction conditions for the RT-PCR were 200 nM per primer, 100 nM per probe, 200 µmol/L of each dNTP, 5 mmol/L MgSO4, and 100 ng total RNA. The PCR cycling conditions were 45 cycles of 95°C for 30 seconds and 60°C for 30 seconds. The mouse integrin β1 sequence was obtained from the GenBank database (NM_010578.1), for which primers and TaqMan probes were designed with primer3 software. Quantification of the amount of target in the unknown samples was accomplished using a standard curve to determine the starting concentration of the target. Gene expression was normalized through dividing the starting concentration of the target by the starting concentration of constitutively expressed β-actin. The standard curve was generated using QPCR mouse reference total RNA (Stratagene).
Statistical Analyses
Each cell culture experiment was repeated 3 times (on separate cultures) and the data are expressed as mean±SD. Analysis was performed using the Student paired t test. Significance was set at P<0.05.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Endothelial Cell and Astrocyte β1 Integrin Expression Is ECM-Dependent
Primary endothelial cells or astrocytes were cultured on single substrates (collagen IV, fibronectin, laminin, or the HSPG perlecan) which are the major proteins present within the basal lamina of primate cerebral blood vessels (Figure 1). Collagen I, not present in the vascular basal lamina, but induced in interstitial tissues in states of remodeling, served as an "external" control. The cell surface integrin expressions of endothelial cells and astrocytes, grown for 3 days on each substrate, were quantified by flow cytometry using monoclonal antibodies specific for the integrin subunits.33
|
Endothelial expression of the integrin β1 and 5 subunits was significantly increased by collagen I, collagen IV, fibronectin, and perlecan compared with plastic (Figures 2, 3, 4, and 5
). Perlecan was most stimulating. Integrin 6 subunit expression was significantly increased on fibronectin, but decreased on laminin. However, 1 or 3 presentation was not significantly affected by any substrate.
|
|
|
|
In contrast, overall, astrocytes displayed a rather small decrease in integrin expression in response to the ECM proteins (Figures 2 and 3
). In particular, astrocyte 5 and 6 subunit expression decreased by exposure to fibronectin and laminin, and 6 expression was also reduced on collagen I and HSPG. Expression of the 1 or 3 subunits by astrocytes was not affected by any substrate.
Taken together, these observations demonstrate that integrin expression by vascular endothelial cells and astrocytes is differentially regulated in a cell- and ECM substrate–specific manner. Establishing the ECM-dependence of baseline integrin expression paves the way for analyzing the influence of ischemia on these events.
Integrin Expression Is Influenced by Oxygen-Glucose Deprivation
Focal cerebral ischemia induces a rapid loss of integrin expression by endothelial cells and astrocyte end-feet in vivo.23,25,34 To determine whether ischemia per se is responsible for this, the impact of standardized ischemia (OGD) on integrin expression by primary brain endothelial cell and astrocyte cultures was determined. Standardized OGD had little impact on cell viability. In both endothelial and astrocyte cultures there was only 0.8% to 1.7% increase in cell death in the OGD-treated cultures compared with normoxia across all substrates (data not shown).
Endothelial cells exposed to OGD, demonstrated significantly increased expression of the 5 integrin subunit on all 3 ECM substrates, but showed no changes in subunits 1, 3, or 6. Moreover, OGD induced a large significant increase in endothelial cell expression of the β1 integrin subunit on all 3 substrates (Figures 2 and 4).
However, OGD significantly reduced the expression levels of both 1 and 6 integrin subunits by astrocytes cultured on all 3 ECM substrates (Figures 2 and 4), but 3 and 5 subunit expression was not significantly affected. In contrast, ischemia induced a large significant increase in astrocyte expression of the β1 integrin subunit on laminin and HSPG. This was supported by an overall increase in subunit β1 transcription by astrocytes, that was significant when the cells were grown on plastic (Figure 5).
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
As early as 2 hours after the onset of cerebral ischemia in the nonhuman primate, microvascular endothelial cells and astrocytes display significant loss in integrin expression.23,24 This is accompanied by alterations in the vascular basal lamina matrix.13,26,35 Because these events coincide with increased cerebrovascular permeability,36 loss of endothelial and astrocyte adhesion to the microvascular basal lamina may be an early pivotal event that contributes to loss of the microvascular permeability barrier. In the neurovascular unit, the proximity of astrocyte end-feet to the abluminal surface of the endothelium suggests roles in integrin signaling by the matrix in both cell compartments that support their maintenance of the permeability barrier.
To characterize these events we first examined how integrin expression by endothelial cells and astrocytes is regulated by matrix proteins present in the basal lamina, and then by ischemia caused by OGD. The major findings are that (1) whereas astrocyte integrin expression was relatively unaffected by exposure to the ECM substrate, the expressions of subunits β1 and 5 by endothelium were promoted by all ECM ligands, particularly perlecan; (2) OGD induced significant changes in integrin expression of both astrocytes and endothelial cells; and (3) during OGD the murine cell responses largely recapitulated the basic changes in microvascular integrin expression observed during focal cerebral ischemia in the nonhuman primate.
It is important to establish the direct influence of basal lamina ECM proteins on cellular integrin expression levels as a primary step in understanding their contribution to potential signaling effects within endothelial cells and astrocytes in vivo. Previous studies with other cell types have shown that cellular expression of integrins can be strongly influenced by the matrix ligands on which they are cultured.37,38 Here, it was necessary to establish the baseline conditions required to grow cells on physiologically relevant basal lamina matrix substrates before investigating the influence of ischemia in vitro. Both cell- and ECM-dependence of integrin expression were observed. Expression of the β1 subunit on cultured astrocytes was relatively constant regardless of the substrate. Although several matrix proteins induced small reductions in astrocyte integrin expression, this was only consistent for the 6 subunit for cells grown on fibronectin, laminin, or HSPG. In contrast, endothelial expressions of both β1 and 5 integrin subunits were stimulated by nearly all ECM substrates, in particular HSPG.
Characteristic cell-specific changes in integrin expression in response to experimental ischemia, which were generally reproducible across collagen IV, laminin, and HSPG for each cell type, were observed. For astrocytes, OGD induced a broadly significant loss of the integrin subunits 1 and 6. This finding is consistent with the loss of both integrin subunits after focal cerebral ischemia in vivo, in both the ischemic core and periphery, in the nonhuman primate.23,24 In vivo, integrin 6β4, unique to astrocyte end-feet, is lost within 2 hours after middle cerebral artery occlusion.24 Here, the reduction in the 6 subunit (which solely partners subunit β4) exactly mirrors the loss of 6β4 in vivo. Furthermore, subunit 1 expression decreases significantly from astrocytes very early during focal ischemia in the nonhuman primate,25 as observed in vitro. This suggests that for the subunits on primary astrocytes in vitro experiments ischemia represents a good model of the in vivo events and should allow investigation of the molecular mechanisms that underlie the loss of integrin expression by astrocytes.
In contrast to the reduced expression of both 1 and 6 subunits, OGD significantly increased the expression of the β1 integrin subunit on astrocytes (see Table). However, the integrin β1 subunit is lost from cerebral microvessels in the ischemic territory early after middle cerebral artery occlusion.25 The increased β1 expression observed here is supported by the upregulation of β1-transcription by astrocytes in vitro during OGD (Figure 5). Although there is the expectation that subunit expression levels generally follow those of the associated β-subunits, the apparent discrepancy here is important. It can be explained by the induction of another as yet undefined integrin subunit that matches the increased expression of the β1 subunit. Or, astrocyte expression of the 1 and 6 subunits could be more sensitive to ischemia in vitro than the β1 subunit, and therefore precede loss of the β1 subunit.
|
Another explanation is suggested from observation of the endothelial cell responses. On isolated primary endothelial cells, OGD induced an unexpected 2-fold increased expression of the β1 integrin subunit. Indeed, in vivo focal cerebral ischemia induces loss of all endothelial integrins including β1, except for vβ3.23,24 But, the β1 integrin responses by endothelial cells in vitro are consistent with the previous finding of increased β1 integrin mRNA expression by microvessels within regions peripheral to the ischemic cores, but not within the core regions themselves.24 This suggests that brain endothelial cells (and astrocytes) can respond to ischemia by attempting to increase β1 integrin expression levels. One very important implication of this finding is that the conditions initiated by focal ischemia effect changes in microvascular β1 integrin expression by processes which are likely post-transcriptional, as suggested by the in vitro astrocyte responses. This is now being explored.
In contrast to the generalized loss of the integrin subunits on astrocytes, OGD also significantly increased 5 subunit expression on endothelial cells (integrin 5 transcription levels during focal ischemia in vivo have not been measured). The endogenous response of brain endothelial cells to upregulate both the 5 and β1 subunits in response to OGD is very similar to the observation that certain tumor cells can ramp up 5 integrin levels in response to hypoxia (part of the well-described Warburg effect), presumably to enable metastatic cells to attach to ECM proteins in settings of oxygen stress.39
There are some important caveats to interpreting these observations. The endothelial cell cultures in this study derived from relatively pure defined populations. It cannot be ruled-out that in vivo endothelial cell integrin antigens may disappear, not as a direct response to ischemia, but rather by processes emanating either directly from surrounding cells (astrocytes, pericytes, or microglia) or from the blood. Because microglia are present at low levels (5% of total cells) in the astrocyte cultures but not in the endothelial cell cultures,33 it cannot be excluded that the differential responses of endothelial cell- and astrocyte-associated integrin changes to OGD may be due to the presence of these cells in the astrocyte, but not in the endothelial cultures. The situation in vivo is not known.
Recently, we proposed that matrix adhesion receptors could play an important role in maintaining the permeability barrier of the cerebral microvasculature.40 The findings with in vitro ischemia establish both microvascular endothelial cells and astrocytes of murine origin as platforms for examining the adhesion receptor responses of microvascular cells of the neurovascular unit within the primate striatum, and their regulations in vivo.
|
Acknowledgments |
|---|
Sources of Funding
This is manuscript number 18744-MEM from the Scripps Research Institute. The preparation of this manuscript was supported in part by R01 NS026945, R37 NS038710, and R01 NS053716 of the National Institutes of Health. Appreciation is also given to the Stein Endowment Fund which underwrote a portion of the costs of the gene transcription studies.
Disclosures
None.
Received February 23, 2007; revision received May 31, 2007; accepted June 22, 2007.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview. Structure, regulation, and clinical implications. Neurobiol Dis. 2004; 16: 1–13.[CrossRef][Medline] [Order article via Infotrieve]
2. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. 2002; 63: 70–80.[CrossRef][Medline] [Order article via Infotrieve]
3. Pardridge WM. Blood-brain barrier drug targeting: the future of brain drug development. Mol Med. 2003; 3: 90–105.
4. Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2002; 38: 3323–3337.
5. Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci. 1999; 22: 11–28.[CrossRef][Medline] [Order article via Infotrieve]
6. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001; 24: 719–725.[CrossRef][Medline] [Order article via Infotrieve]
7. Engelhardt B. Development of the blood-brain barrier. Cell Tissue Res. 2003; 314: 119–129.[CrossRef][Medline] [Order article via Infotrieve]
8. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat. 2002; 200: 629–638.[CrossRef][Medline] [Order article via Infotrieve]
9. Abbruscato TJ, Davis TP. Protein expression of brain endothelial cell E-cadherin after hypoxia/aglycemia: influence of astrocyte contact. Brain Res. 1999; 842: 277–286.[CrossRef][Medline] [Order article via Infotrieve]
10. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987; 325: 253–257.[CrossRef][Medline] [Order article via Infotrieve]
11. Risau W, Hallmann R, Albrecht U, Henke-Fahle S. Brain astrocytes induce the expression of an early cell surface marker for blood-brain barrier specific endothelium. EMBO J. 1986; 5: 3179–3183.[Medline] [Order article via Infotrieve]
12. Risau W, Esser S, Engelhardt B. Differentiation of blood-brain barrier endothelial cells. Pathologie et Biologie. 1998; 46: 171–175.[Medline] [Order article via Infotrieve]
13. Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke. 1995; 26: 2120–2126.
14. Haring H-P, Akamine P, Habermann R, Koziol JA, del Zoppo GJ. Distribution of the integrin-like immunoreactivity on primate brain microvasculature. J Neuropathol Exp Neurol. 1996; 55: 236–245.[Medline] [Order article via Infotrieve]
15. Grooms SY, Terracio L, Jones LS. Anatomical localization of β1 integrin-like immunoreactivity in rat brain. Exp Neurol. 1993; 122: 253–259.[CrossRef][Medline] [Order article via Infotrieve]
16. Milner R, Campbell IL. Developmental regulation of β1 integrins during angiogenesis in the central nervous system. Mol Cell Neurosci. 2002; 20: 616–626.[CrossRef][Medline] [Order article via Infotrieve]
17. Paulus W, Baur I, Schuppan D, Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol. 1993; 143: 154–163.[Abstract]
18. Kloss CU, Werner A, Klein MA, Shen J, Menuz K, Probst JC, Kreutzberg GW, Raivich G. Integrin family of cell adhesion molecules in the injured brain: regulation and cellular localization in the normal and regenerating mouse facial motor nucleus. J Comp Neurol. 1999; 411: 162–178.[CrossRef][Medline] [Order article via Infotrieve]
19. Previtali SC, Archelos JJ, Hartung HP. Modulation of the expression of integrins on glial cells during experimental autoimmune encephalomyelitis: a central role for TNF-. Am J Pathol. 1997; 151: 1425–1435.[Abstract]
20. Sobel RA, Hinojoza JR, Maeda A, Chen M. Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions. Am J Pathol. 1998; 153: 405–415.
21. Zhu J, Motejlek K, Wang D, Zang K, Schmidt A, Reichardt LF. β8 integrins are required for vascular morphogenesis in mouse embryos. Development. 2002; 129: 2891–2903.[Medline] [Order article via Infotrieve]
22. Bader BL, Rayburn H, Crowley D, Hynes RO. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all V integrins. Cell. 1998; 95: 507–519.[CrossRef][Medline]
[Order article via Infotrieve]
23. Tagaya M, Liu K-F, Copeland B, Seiffert D, Engler R, Garcia JH, del Zoppo GJ. DNA scission after focal brain ischemia: temporal differences in two species. Stroke. 1997; 28: 1245–1254.
24. Wagner S, Tagaya M, Koziol JA, Quaranta V, del Zoppo GJ. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin 6β4 during focal cerebral ischemia/reperfusion. Stroke. 1997; 28: 858–865.
25. Tagaya M, Haring H-P, Stuiver. I., Wagner S, Abumiya T, Lucero J, Lee P, Copeland BR, Seiffert D, del Zoppo GJ. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab. 2001; 21: 835–846.[CrossRef][Medline] [Order article via Infotrieve]
26. Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LL Jr, del Zoppo GJ. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke. 2004; 35: 998–1004.
27. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1996; 16: 1373–1378.[CrossRef][Medline] [Order article via Infotrieve]
28. Wang J, Milner R. Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling. J Neurochem. 2006; 96: 148–159.[Medline] [Order article via Infotrieve]
29. Sapatino BV, Welsh CJ, Smith CA, Bebo BF, Linthicum DS. Cloned mouse cerebrovascular endothelial cells that maintain their differentiation markers for factor VIII, low density lipoprotein, and angiotensin-converting enzyme. In Vitro Cell Dev Biol Anim. 1993; 29A: 923–928.[CrossRef]
30. Milner R, ffrench-Constant C. A developmental analysis of oligodendroglial integrins in primary cells: changes in v-associated β subunits during differentiation. Development. 1994; 120: 3497–3506.[Abstract]
31. Milner R, Huang X, Wu J, Nishimura S, Pytela R, Sheppard D, Ffrench-Constant C. Distinct roles for astrocyte Vβ5 and Vβ8 integrins in adhesion and migration. J Cell Sci. 1999; 112: 4271–4279.[Abstract]
32. McCarthy KD, Vellis JD. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 1980; 85: 890–902.
33. Milner R, Campbell IL. Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the 6β1 integrin. J Neurosci. 2002; 22: 1562–1572.
34. Takada Y, Murphy E, Pil P, Chen C, Ginsberg MH, Hemler ME. Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin, laminin, and collagen. J Cell Biol. 1991; 115: 257–266.
35. Hamann GF, Liebetrau M, Martens H, Burggraf D, Kloss CUA, Bültemeier G, Wunderlich N, Jäger G, Pfefferkorn T. Microvascular basal lamina injury after experimental focal cerebral ischemia and reperfusion in the rat. J Cereb Blood Flow Metab. 2002; 22: 526–533.[CrossRef][Medline] [Order article via Infotrieve]
36. Abumiya T, Lucero J, Heo JH, Tagaya M, Koziol JA, Copeland BR, del Zoppo GJ. Activated microvessels express vascular endothelial growth factor and integrin vβ3 during focal cerebral ischemia. J Cereb Blood Flow Metab. 1999; 19: 1038–1050.[CrossRef][Medline]
[Order article via Infotrieve]
37. Streuli CH, Bissell MJ. Expression of extracellular matrix components is regulated by substratum. J Cell Biol. 1990; 110: 1405–1415.
38. Milner R, Campbell IL. The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol. 2003; 170: 3850–3858.
39. Koike T, Kimura N, Miyazaki K, Yabuta T, Kumamoto K, Takenoshita S, Chen J, Kobayashi M, Hosokawa M, Taniguchi A, Kojima T, Ishida N, Kawakita M, Yamamoto H, Takematsu H, Suzuki A, Kozutsumi Y, Kannagi R. Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci U S A. 2004; 101: 8132–8137.
40. del Zoppo GJ, Milner R. Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol. 2006; 26: 1966–1975.
This article has been cited by other articles:
 |
|
 |
|
  C. V. Borlongan Cell Therapy for Stroke: Remaining Issues to Address Before Embarking on Clinical Trials Stroke, March 1, 2009; 40(3_suppl_1): S146 - S148. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||